Top

CardioVascular and Interventional Radiology

Published in:

01-06-2012 | Technical Note

Transarterial Ethylene Vinyl Alcohol Copolymer Visualization and Penetration After Embolization of Life-Threatening Hemoptysis: Technical and Clinical Outcomes

Authors: Sébastien Bommart, Arnaud Bourdin, Marie France Giroux, François Klein, Antoine Micheau, Valérie Monnin Bares, Hélène Kovacsik

Published in: CardioVascular and Interventional Radiology | Issue 3/2012

Abstract

Objectives

This study was designed to evaluate the feasibility of using ethylene vinyl alcohol copolymer (EVAC) for bronchial artery embolization (BAE) in patients with life-threatening hemoptysis and to compare the visualization and transarterial penetration of EVAC under fluoroscopy and computed tomography (CT).

Methods

Fifteen patients (mean age, 62.9 (range, 24–82) years) who were referred for life-threatening hemoptysis (27 month period) underwent BAE using EVAC. All patients had thoracic CT examination before and after BAE. Technical and clinical results were evaluated. Visibility and extent of cast penetration (graded 1–4) on fluoroscopy and postprocedure CT were assessed and compared.

Results

BAE was feasible in all but one artery (due to spasm; n = 27; 96.4%). No procedure-related complications or deaths were detected. Two patients had recurrent bleeding in the following day (13.3%). Immediate clinical success was achieved in 14 cases (93.3%) after reembolization of pulmonary artery pseudoaneurysm in one patient (mean follow-up, 43.5 (range, 14–148) days). Visibility of the cast was possible in 73.3% of patients (n = 11) under fluoroscopy (mean cast penetration 1.66) and in all patients under CT (mean cast penetration 2.06). The postinjection fluoroscopic visibility in 6 of 15 (40%) patients was inferior to CT (P < 0.02).

Conclusions

BAE with EVAC seems to be feasible and safe with immediate control of hemoptysis in most patients. The postinjection fluoroscopic visibility of EVAC under fluoroscopy was inferior to CT.

Remy J, Voisin C, Ribet M et al (1973) Treatment, by embolization, of severe or repeated hemoptysis associated with systemic hypervascularization. Nouv Presse Med 2(31):2060PubMed

Yoo DH, Yoon CJ, Kang SG et al (2011) Bronchial and nonbronchial systemic artery embolization in patients with major hemoptysis: safety and efficacy of N-butyl cyanoacrylate. AJR Am J Roentgenol 196(2):W199–W204PubMedCrossRef

Baltacioğlu F, Cimşit NC, Bostanci K et al (2010) Transarterial microcatheter glue embolization of the bronchial artery for life-threatening hemoptysis: technical and clinical results. Eur J Radiol 73(2):380–384PubMedCrossRef

Tamiya H, Hirano S, Morii S et al (2009) Case of repeated hemoptysis successfully treated with bronchial artery embolization with N-butyl cyanoacrylate. Nihon Kokyuki Gakkai Zasshi 47:427–431PubMed

Razavi MK, Murphy K (2007) Embolization of bronchial arteries with N-butyl cyanoacrylate for management of massive hemoptysis: a technical review. Tech Vasc Interv Radiol 10(4):276–282PubMedCrossRef

van Rooij WJ, Sluzewski M, Beute GN (2007) Brain AVM embolization with Onyx. AJNR Am J Neuroradiol 28(1):172–177PubMed

Panagiotopoulos V, Gizewski E, Asgari S et al (2009) Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol 30(1):99–106PubMedCrossRef

Lenhart M, Paetzel C, Sackmann M et al (2010) Superselective arterial embolisation with a liquid polyvinyl alcohol copolymer in patients with acute gastrointestinal haemorrhage. Eur Radiol 20(8):1994–1999PubMedCrossRef

Loffroy R, Rao P, Kwak BK et al (2011) Superselective arterial embolisation with a liquid polyvinyl alcohol copolymer in patients with acute gastrointestinal haemorrhage. Eur Radiol 21(1):213 LetterPubMedCrossRef

10.

Muller-Wille R, Heiss P, Herold T et al (2011) Endovascular treatment of acute arterial hemorrhage in trauma patients using ethylene vinyl alcohol copolymer (Onyx). Cardiovasc Intervent Radiol 21(1):10–12

11.

Khalil A, Fartoukh M, Bazot M et al (2010) Systemic arterial embolization in patients with hemoptysis: initial experience with ethylene vinyl alcohol copolymer in 15 cases. AJR Am J Roentgenol 194(1):W104–W110PubMedCrossRef

12.

Adamus Nurnberg R, Uder Erlangen M, Kleinschmidt T et al (2010) Embolization of acute abdominal and thoracic hemorrhages with ethylene vinyl alcohol copolymer (Onyx): initial experiences with arteries of the body trunk. Rofo 182:900–904PubMedCrossRef

13.

Pierce G, Ahuja C, Chadha M (2011) Case report: complex internal mammary to pulmonary artery fistula as a cause of hemoptysis in tuberculosis: diagnosis and endovascular management using ethylene vinyl alcohol copolymer (Onyx). Indian J Radiol Imaging 21:10–12PubMedCrossRef

14.

Fartoukh M, Khalil A, Louis L et al (2007) An integrated approach to diagnosis and management of severe haemoptysis in patients admitted to the intensive care unit: a case series from a referral centre. Respir Res 15:8–11

15.

Shigemura N, Wan IY, Yu SC et al (2009) Multidisciplinary management of life-threatening massive hemoptysis: a 10 year experience. Ann Thorac Surg 87(3):849–853PubMedCrossRef

16.

Chun JY, Morgan R, Belli AM (2010) Radiological management of hemoptysis: a comprehensive review of diagnostic imaging and bronchial arterial embolization. Cardiovasc Intervent Radiol 33(2):240–250PubMedCrossRef

17.

Ong TH, Eng P (2003) Massive hemoptysis requiring intensive care. Intensive Care Med 29(2):317–320PubMed

18.

Angle JF, Siddiqi NH, Wallace MJ et al (2010) Quality improvement guidelines for percutaneous transcatheter embolization: society of interventional radiology standards of practice committee. J Vasc Interv Radiol 21(10):1479–1486PubMedCrossRef

19.

Yoon W, Kim JK, Kim YH et al (2002) Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review. Radiographics 22(6):1395–1409PubMedCrossRef

20.

Corr PD (2005) Bronchial artery embolization for life-threatening hemoptysis using tris-acryl microspheres: short-term result. Cardiovasc Intervent Radiol 28(4):439–441PubMedCrossRef

21.

Gobin YP, Murayama Y, Milanese K et al (2001) Head and neck hypervascular lesions: embolization with ethylene vinyl alcohol copolymer-laboratory evaluation in Swine and clinical evaluation in humans. Radiology 221:309–317PubMedCrossRef

Title: Transarterial Ethylene Vinyl Alcohol Copolymer Visualization and Penetration After Embolization of Life-Threatening Hemoptysis: Technical and Clinical Outcomes
Authors: Sébastien Bommart
Arnaud Bourdin
Marie France Giroux
François Klein
Antoine Micheau
Valérie Monnin Bares
Hélène Kovacsik
Publication date: 01-06-2012
Publisher: Springer-Verlag
Published in: CardioVascular and Interventional Radiology / Issue 3/2012
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-011-0270-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Transarterial Ethylene Vinyl Alcohol Copolymer Visualization and Penetration After Embolization of Life-Threatening Hemoptysis: Technical and Clinical Outcomes

Abstract

Objectives

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2012

Lung Radiofrequency Ablation for the Treatment of Unresectable Recurrent Non-Small-Cell Lung Cancer After Surgical Intervention

Recurrent Bleeding Within 24 Hours After Uterine Artery Embolization for Severe Postpartum Hemorrhage: Are There Predictive Factors?

Workflow Optimization in Vertebrobasilar Occlusion

A Signal-Inducing Bone Cement for Magnetic Resonance Imaging-Guided Spinal Surgery Based on Hydroxyapatite and Polymethylmethacrylate

Stereotactic Radiofrequency Ablation (SRFA) of Liver Lesions: Technique Effectiveness, Safety, and Interoperator Performance

Reverse Chimney or Periscope: Some Issues have to be Addressed “Re Endovascular Aneurysm Repair Using a Reverse Chimney Technique in a Patient with Marfan Syndrome and Contained Ruptured Chronic Type B Dissection”: Reply